Heterologous prime-boost immunizations with different Salmonella serovars for enhanced antigen-specific CD8 T-cell induction

Vaccine

Volumn 26, Issue 15, 2008, Pages 1879-1886

  Sevil Domènech, Victòria E ^a   Panthel, Klaus ^a   Winter, Sebastian E ^a   Rüssmann, Holger ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Anti vector immunity; CD8 T cell; Heterologous prime boost immunizations; Salmonella enterica serovar Typhimurium and serovar Dublin; Type III secretion system

Indexed keywords

BRD 620; LIVE VACCINE; SALMONELLOSIS VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL STRAIN; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; FEMALE; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALMONELLA; SEROTYPE; T LYMPHOCYTE ACTIVATION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CECUM; COLONY COUNT, MICROBIAL; FEMALE; IMMUNIZATION, SECONDARY; INTERFERON TYPE II; LYMPH NODES; MICE; MICE, INBRED BALB C; PEYER'S PATCHES; SALMONELLA ENTERICA; SALMONELLA VACCINES; SPLEEN;

EID: 40849135857     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.01.044     Document Type: Article

References (25)

1. Rüssmann H., Shams H., Poblete F., Fu Y., Galán J.E., and Donis R.O. Delivery of epitopes by the Salmonella type III secretion system for vaccine development. Science 281 (1998) 565-568
2. Panthel K., Meinel K.M., Sevil Domènech V.E., Trülzsch K., and Rüssmann H. Salmonella type III-mediated antigen delivery: a versatile oral vaccination strategy to induce cellular immunity against infectious agents and tumors. Int J Med Microbiol 298 (2008) 99-103
3. Rüssmann H., Igwe E.I., Sauer J., Hardt W.-D., Bubert A., and Geginat G. Protection against murine listeriosis by oral vaccination with recombinant Salmonella expressing hybrid Yersinia type III proteins. J Immunol 167 (2001) 357-365
4. Sevil Domènech V.E., Panthel K., Meinel K.M., and Rüssmann H. Rapid clearance of a recombinant Salmonella vaccine carrier prevents enhanced antigen-specific CD8 T-cell responses after oral boost immunizations. Microbes Infect 7 (2005) 860-866
5. Sevil Domènech V.E., Panthel K., Meinel K.M., Winter S.E., and Rüssmann H. Pre-existing anti-Salmonella vector immunity prevents the development of protective antigen-specific CD8 T-cell frequencies against murine listeriosis. Microbes Infect 9 (2007) 1447-1453
6. Kaniga K., Uralil J., Bliska J.B., and Galán J.E. A secreted protein tyrosine phosphatase with modular effector domains in the bacterial pathogen Salmonella typhimurium. Mol Microbiol 21 (1996) 633-641
7. Hoiseth S.K., and Stocker B.A. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291 (1981) 238-239
8. Roberts M., Bacon A., Li J., and Chatfield S. Prior immunity to homologous and heterologous Salmonella serotypes suppresses local and systemic anti-fragment C antibody responses and protection from tetanus toxin in mice immunized with Salmonella strains expressing fragment C. Infect Immun 67 (1999) 3810-3815
9. Galán J.E. Interactions of Salmonella with host cells: encounters of the closest kind. Proc Natl Acad Sci USA 95 (1998) 14006-14008
10. Collazo C.M., and Galán J.E. Requirement for exported proteins in secretion through the invasion-associated type III system of Salmonella typhimurium. Infect Immun 64 (1996) 3524-3531
11. Vijh S., and Pamer E.G. Immunodominant and subdominant CTL responses to Listeria monocytogenes infection. J Immunol 158 (1997) 3366-3371
12. Chen L.-M., Briones G., Donis R.O., and Galán J.E. Optimization of the delivery of heterologous proteins by the Salmonella enterica serovar Typhimurium type III secretion system for vaccine development. Infect Immun 74 (2006) 5826-5833
13. Köhler S.A., Bubert A., Vogel M., and Goebel W. Expression of the iap gene coding for protein p60 of Listeria monocytogenes is controlled on the posttranscriptional level. J Bacteriol 173 (1991) 4668-4674
14. Pamer E.G., Harty J.T., and Bevan M.J. Precise prediction of a dominant class-I restricted epitope of Listeria monocytogenes. Nature 353 (1991) 852-855
15. Pamer E.G. Direct sequence identification and kinetic analysis of an MHC class I-restricted Listeria monocytogenes CTL epitope. J Immunol 152 (1994) 686-694
16. Kotton C.N., and Hohmann E.L. Enteric pathogens as vaccine vectors for foreign antigen delivery. Infect Immun 72 (2004) 5535-5547
17. Medina E., and Guzman C.A. Use of live bacterial vaccine vectors for antigen delivery: potential and limitations. Vaccine 19 (2001) 1573-1580
18. Schodel F., and Curtiss III R. Salmonellae as oral vaccine carrier. Dev Biol Stand 84 (1995) 245-253
19. Bao J.X., and Clements J.D. Prior immunologic experience potentiates the subsequent antibody response when Salmonella strains are used as vaccine carriers. Infect Immun 59 (1991) 3841-3845
20. Whittle B.L., and Verma N.K. The immune response to a B-cell epitope delivered by Salmonella is enhanced by prior immunological experience. Vaccine 15 (1997) 1737-1740
21. Attridge S.R., Davies R., and LaBrooy J.T. Oral delivery of foreign antigens by attenuated Salmonella: consequences of prior exposure to the vector strain. Vaccine 15 (1997) 155-162
22. Vindurampulle C.J., and Attridge S.R. Impact on vector priming on the immunogenicity of recombinant Salmonella vaccines. Infect Immun 71 (2003) 287-297
23. Lindberg A.A., Segall T., Weintraub A., and Stocker B.A.D. Antibody response and protection against challenge in mice vaccinated intraperitoneally with live aroA O4, O9 hybrid Salmonella Dublin strain. Infect Immun 61 (1993) 1211-1221
24. Fang F.C., and Fierer J. Human infection with Salmonella dublin. Medicine (Baltimore) 70 (1991) 198-207
25. Taylor D.N., Bied J.M., Munro J.S., and Feldman R.A. Salmonella Dublin infections in the United States. J Infect Dis 146 (1982) 322-327